Conversely, expression of GLUD2 (but not GLUD1) promotes tumor expansion, suggesting that R132H IDH1 glioma cells proliferate by utilizing enhanced glutamate flux through the GLUD2 pathway [126]. The gene discussed is GLUD2; the disease is central nervous system cancer.